Literature DB >> 16542285

Helicobacter pylori treatment: a practical approach.

Nimish Vakil.   

Abstract

The treatment of Helicobacter pylori infection has become complicated by the lack of new treatment regimens and the emergence of drug resistant strains of H. pylori. Metronidazole and clarithromycin resistance are common in developed countries. Eradication rates have been falling in trials and in clinical practice around the world. A practical approach to the treatment of patients with H. pylori infection and those who fail initial eradication therapy is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16542285     DOI: 10.1111/j.1572-0241.2006.00454.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  16 in total

1.  Atomic force microscopy measurements reveal multiple bonds between Helicobacter pylori blood group antigen binding adhesin and Lewis b ligand.

Authors:  P Parreira; Q Shi; A Magalhaes; C A Reis; J Bugaytsova; T Borén; D Leckband; M C L Martins
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

Review 2.  Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults.

Authors:  Kate McKeage; Stephanie K A Blick; Jamie D Croxtall; Katherine A Lyseng-Williamson; Gillian M Keating
Journal:  Drugs       Date:  2008       Impact factor: 9.546

3.  13C-urea breath test values and Helicobacter pylori eradication.

Authors:  Angelo Zullo; Federico Perna; Chiara Ricci; Cesare Hassan; Andrea Tampieri; Vincenzo De Francesco; Sergio Morini; Dino Vaira
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease.

Authors:  Vassilios Koussoulas; Spyridon Vassiliou; Ekaterini Spyridaki; Maria Demonakou; Ilia Vaki; Charalambos Barbatzas; Helen Giamarellou; Evangelos J Giamarellos-Bourboulis
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

5.  Efficacy of a new therapeutic regimen versus two routinely prescribed treatments for eradication of Helicobacter pylori: a randomized, double-blind study of doxycycline, co-amoxiclav, and omeprazole in Iranian patients.

Authors:  Seyed Alireza Taghavi; Ali Jafari; Ahad Eshraghian
Journal:  Dig Dis Sci       Date:  2008-07-02       Impact factor: 3.199

6.  Docosahexaenoic acid inhibits Helicobacter pylori growth in vitro and mice gastric mucosa colonization.

Authors:  Marta Correia; Valérie Michel; António A Matos; Patrícia Carvalho; Maria J Oliveira; Rui M Ferreira; Marie-Agnès Dillies; Michel Huerre; Raquel Seruca; Ceu Figueiredo; Jose C Machado; Eliette Touati
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

7.  Structural Basis for the Inhibition of Helicobacter pylori α-Carbonic Anhydrase by Sulfonamides.

Authors:  Joyanta K Modak; Joyanta K Modakh; Yu C Liu; Mayra A Machuca; Claudiu T Supuran; Anna Roujeinikova
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

8.  Efficacy of microencapsulated lactic acid bacteria in Helicobater pylori eradication therapy.

Authors:  Maha A Khalil; Mostafa M El-Sheekh; Hala I El-Adawi; Nehal M El-Deeb; Mohamed Z Hussein
Journal:  J Res Med Sci       Date:  2015-10       Impact factor: 1.852

9.  Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsia.

Authors:  Shahram Agah; Babak Shazad; Babak Abbaszadeh
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

Review 10.  Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy.

Authors:  Luigi Gatta; Nimish Vakil; Dino Vaira; Carmelo Scarpignato
Journal:  BMJ       Date:  2013-08-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.